+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell Culture Market by Product, Application, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995205
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell Culture Market grew from USD 26.29 billion in 2023 to USD 30.12 billion in 2024. It is expected to continue growing at a CAGR of 14.58%, reaching USD 68.20 billion by 2030.

Cell culture, a fundamental process in biotechnology and pharmaceutical research, involves the growth and maintenance of cells in a controlled artificial environment. It is essential for studying cellular development, understanding disease mechanisms, and paving paths for drug discovery and biomanufacturing. The necessity of cell culture lies in its applications across drug screening, regenerative medicine, stem cell research, oncology, and vaccine production. Key end-users include pharmaceutical and biotech companies, hospitals, academic institutions, and research laboratories. The market's growth is largely driven by an increased demand for biopharmaceuticals and the rising prevalence of chronic diseases fueling research activities. Technological advancements in 3D cell culture, developments in regenerative medicine, and personalized medicine are presenting lucrative opportunities for market players. However, challenges such as high costs of equipment and reagents, ethical concerns regarding animal-derived culture materials, and the complexity of replicating a fully natural environment may impede growth. Emerging trends like the integration of artificial intelligence and machine learning into cell culture processes offer promising innovation opportunities. These could enhance process efficiency, predict cellular responses, and optimize nutrient supplies, leading to more sustainable practices. The application of CRISPR and other gene-editing technologies into cell culture systems is another growth area, promising precision therapy developments. Companies should focus on developing cost-effective, scalable culture systems and prioritizing ethical considerations to circumvent limitations. Further, investing in R&D to advance automated systems for large-scale operations presents a viable pathway to address the industry's scalability challenges. Exploring the development of hybrid systems combining 3D bioprinting and cell culture also holds potential. Overall, while the cell culture market is poised for growth, adaptive strategies focusing on innovation, ethical considerations, and cost efficiencies will be crucial for capitalizing on emerging opportunities.

Understanding Market Dynamics in the Cell Culture Market

The Cell Culture Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing demand for monoclonal antibodies for therapeutic applications
    • Increased investment in biotechnology and pharmaceutical research activities
    • Rising incidence of chronic diseases worldwide
  • Market Restraints
    • High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
  • Market Opportunities
    • Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
    • Burgeoning demand for cultured meat, using cell culture for sustainable food production
  • Market Challenges
    • The complexity of maintaining cultures and the risk of contamination

Exploring Porter’s Five Forces for the Cell Culture Market

Porter’s Five Forces framework further strengthens the insights of the Cell Culture Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell Culture Market

External macro-environmental factors deeply influence the performance of the Cell Culture Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell Culture Market

The Cell Culture Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Culture Market

The Cell Culture Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cell Culture Market

The Cell Culture Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kühner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
      • Bioreactor Accessories
      • Sera, Media, and Reagents
        • Media
          • Classical Media & Salts
          • Serum-Free Media
          • Specialty Media
          • Stem Cell Culture Media
        • Reagents
          • Antibiotics/Antimycotics
          • Attachment & Matrix Factors
          • Balanced Salt Solutions
          • Buffers & Chemicals
          • Cell Dissociation Reagents
          • Contamination Detection Kits
          • Cryoprotective Reagents
        • Sera
          • Adult Bovine Sera
          • Fetal Bovine Sera
      • Vessels
        • Cell Factory Systems/Cell Stacks
        • Flasks
        • Multiwell Plates
        • Petri Dishes
        • Roller/Roux Bottles
    • Equipment
      • Bioreactors
        • Conventional Bioreactors
        • Single-Use Bioreactors
      • Storage Equipment
        • Cryostorage System
        • Refrigerators & Freezers
      • Supporting Equipment
        • Autoclaves
        • Biosafety Cabinets
        • Carbon Dioxide Incubators
        • Cell Counters
        • Centrifuges
        • Filtration System
        • Microscopes
  • Application
    • Biopharmaceutical Production
      • Monoclonal Antibody Production
      • Vaccine Production
    • Diagnostics
    • Drug Screening & Development
    • Stem Cell Research
    • Tissue Engineering & Regenerative Medicine
  • End-Use
    • Hospitals & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
5.1.1.3. Rising incidence of chronic diseases worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
5.1.3. Opportunities
5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
5.1.4. Challenges
5.1.4.1. The complexity of maintaining cultures and the risk of contamination
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cell Culture Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Bioreactor Accessories
6.2.2. Sera, Media, and Reagents
6.2.2.1. Media
6.2.2.1.1. Classical Media & Salts
6.2.2.1.2. Serum-Free Media
6.2.2.1.3. Specialty Media
6.2.2.1.4. Stem Cell Culture Media
6.2.2.2. Reagents
6.2.2.2.1. Antibiotics/Antimycotics
6.2.2.2.2. Attachment & Matrix Factors
6.2.2.2.3. Balanced Salt Solutions
6.2.2.2.4. Buffers & Chemicals
6.2.2.2.5. Cell Dissociation Reagents
6.2.2.2.6. Contamination Detection Kits
6.2.2.2.7. Cryoprotective Reagents
6.2.2.3. Sera
6.2.2.3.1. Adult Bovine Sera
6.2.2.3.2. Fetal Bovine Sera
6.2.3. Vessels
6.2.3.1. Cell Factory Systems/Cell Stacks
6.2.3.2. Flasks
6.2.3.3. Multiwell Plates
6.2.3.4. Petri Dishes
6.2.3.5. Roller/Roux Bottles
6.3. Equipment
6.3.1. Bioreactors
6.3.1.1. Conventional Bioreactors
6.3.1.2. Single-Use Bioreactors
6.3.2. Storage Equipment
6.3.2.1. Cryostorage System
6.3.2.2. Refrigerators & Freezers
6.3.3. Supporting Equipment
6.3.3.1. Autoclaves
6.3.3.2. Biosafety Cabinets
6.3.3.3. Carbon Dioxide Incubators
6.3.3.4. Cell Counters
6.3.3.5. Centrifuges
6.3.3.6. Filtration System
6.3.3.7. Microscopes
7. Cell Culture Market, by Application
7.1. Introduction
7.2. Biopharmaceutical Production
7.2.1. Monoclonal Antibody Production
7.2.2. Vaccine Production
7.3. Diagnostics
7.4. Drug Screening & Development
7.5. Stem Cell Research
7.6. Tissue Engineering & Regenerative Medicine
8. Cell Culture Market, by End-Use
8.1. Introduction
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research & Academic Institutes
9. Americas Cell Culture Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell Culture Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cell Culture Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL CULTURE MARKET DYNAMICS
TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 116. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 118. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 119. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 120. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 121. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 122. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 123. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 124. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 125. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 127. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 186. CHINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. CHINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 188. CHINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 189. CHINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 190. CHINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. CHINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 192. CHINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 193. CHINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 194. CHINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 195. CHINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 196. CHINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 197. CHINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. CHINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 199. CHINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 200. INDIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. INDIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 202. INDIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 203. INDIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 204. INDIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 205. INDIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 206. INDIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 207. INDIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 208. INDIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 209. INDIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 210. INDIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 211. INDIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. INDIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 213. INDIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 228. JAPAN CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. JAPAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 230. JAPAN CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 231. JAPAN CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 232. JAPAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 233. JAPAN CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 234. JAPAN CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 235. JAPAN CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 236. JAPAN CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 237. JAPAN CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 238. JAPAN CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 239. JAPAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. JAPAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 241. JAPAN CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 244. MALAYSIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 273. SINGAPORE CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 274. SINGAPORE CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH KOREA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SOUTH KOREA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH KOREA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 288. SOUTH KOREA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 289. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 290. SOUTH KOREA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 298. TAIWAN CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. TAIWAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 300. TAIWAN CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 301. TAIWAN CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 302. TAIWAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 303. TAIWAN CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 304. TAIWAN CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 305. TAIWAN CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 306. TAIWAN CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 312. THAILAND CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. THAILAND CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 314. THAILAND CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 315. THAILAND CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 316. THAILAND CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 317. THAILAND CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 318. THAILAND CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 319. THAILAND CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 320. THAILAND CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 321. THAILAND CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 322. THAILAND CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 326. VIETNAM CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 327. VIETNAM CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 328. VIETNAM CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 329. VIETNAM CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 330. VIETNAM CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 331. VIETNAM CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 332. VIETNAM CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 333. VIETNAM CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 334. VIETNAM CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 335. VIETNAM CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 336. VIETNAM CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 337. VIETNAM CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. VIETNAM CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 339. VIETNAM CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 355. DENMARK CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 356. DENMARK CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 357. DENMARK CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 358. DENMARK CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 359. DENMARK CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 360. DENMARK CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
TABLE 361. DENMARK CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
TABLE 362. DENMARK CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 363. DENMARK CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 364. DENMARK CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 365. DENMARK CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 366. DENMARK CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 367. DENMARK CELL CULTURE MARKET SIZE, BY BIOP

Companies Mentioned

The leading players in the Cell Culture Market, which are profiled in this report, include:
  • Adolf Kühner AG
  • Advancion Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • Bio-Techne Corporation
  • BioSpherix Ltd.
  • Caisson Labs Inc.
  • CellGenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Emulate, Inc.
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Hi-Media Laboratories
  • InSphero AG
  • Invivogen
  • Lonza Group
  • Merck & Co., Inc.
  • Miltenyi Biotec
  • PAN-Biotech GmbH
  • PromoCell GmbH
  • Sartorius AG
  • Solida Biotech GmBH
  • STEMCELL Technologies Canada Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC by Avantor, Inc.

Methodology

Loading
LOADING...

Table Information